Arrhythmias & electrophysiology
Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association
Authors' conclusion
The STEEER-AF trial was successfully deployed across six European countries to investigate guideline adherence in real-world practice and evaluate if a structured educational programme for healthcare professionals can improve patient-level care.
Study context
- Population
- Patients with atrial fibrillation (AF) in routine practice, France, Germany, Italy, Poland, Spain and UK, 2022–23
- Participants
- 1,732 patients70 centres
- Comparison
- Targeted educational programme for healthcare professionals vs no programme
Methodological detailspragmatic, 70 centres in 6 European countries
- Pragmatic
- 70 centres in 6 European countries
Primary result
As reported in the abstract
Baseline characteristics · enrolment
- Age, mean (SD 11.7)
- 68.9 years
- CHA2DS2-VASc score, mean (SD 1.8)
- 3.2
- Women
- 647 (37%)
- In AF at enrolment
- 843 (49%)
- In sinus rhythm
- 760 (44%)
- OAC prescribed
- 1543 (89%)
- DOAC (of OAC)
- 1378; 89%
- Previous cardioversion, antiarrhythmic drug or ablation
- 836 (48.3%)
- Currently receiving antiarrhythmic drug
- 551 (31.8%)
- Scheduled for future cardioversion or ablation
- 446 (25.8%)
- Healthcare professionals engaged in educational programme
- 195
Original publication
Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association. Europace. Published 28 June 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →